PTPRZ1-Positive Tumor Vaccine (Altevax)

N/A

Report date: 2026/04/21 20:00:18

Base Information

Drug NamePTPRZ1-Positive Tumor Vaccine (Altevax)
Drug Alias NameVaccines against ptprz1-positive tumors (Altevax)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Polypeptide vaccine
Mechanisms of ActionImmunostimulants
TargetsReceptor-type tyrosine-protein phosphatase zeta
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAltevax BioscienceAssistance Publique Hopitaux De ParisUniversité Paris Cité
China Registration ClassN/A

Develop Information

Active CompaniesAltevax BioscienceUniversité Paris CitéAssistance Publique Hopitaux De Paris
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A